InvestorsHub Logo
Followers 8
Posts 2087
Boards Moderated 0
Alias Born 07/31/2006

Re: None

Thursday, 07/17/2014 8:57:36 AM

Thursday, July 17, 2014 8:57:36 AM

Post# of 146291
The reason TOX studies have taken longer than expected to begin is that NanoViricides has needed to produce far greater quantities of the FluCide drug then they initially expected in order to attempt to demonstrate toxicity.

The reason behind this is a good thing. It's because the FluCide drug has demonstrated NO TOXICITY in any of the 5,000+ animals to which it has been administered through years of pre-clinical trials. That reason, perversely, is a complication now as we await the beginning of TOX studies. It will, however, in the long run, be a huge positive.

The drugs have proven so non-toxic in pre-clinical animal studies that they might need to make enough to just drown the animals in it for the TOX studies, because that might be the only way to show any harm.

It's such a strange problem to have, one that's causing delays here at this early stage, but a problem I'm happy to have. And we now have the new production facility completed and soon to begin drug production, greatly increasing the quantities that can be produced. We're nearing the end of the wait for TOX to begin.


Best to all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News